Effects of Methotrexate on Cholesterol Metabolism in Rheumatoid Arthritis Patients
Author Information
Author(s): Chen Der-Yuan, Chih Hui-Min, Lan Joung-Liang, Chang Hsin-Yueh, Chen Wei-Wen, Chiang En-Pei Isabel
Primary Institution: Department of Food Science & Biotechnology, National Chung Hsing University, Taichung, Taiwan
Hypothesis
Is clinical use of low-dose methotrexate associated with altered blood lipids and/or ABCA1/HY27 expressions?
Conclusion
The study found that low-dose methotrexate treatment is associated with increased expressions of atheroprotective proteins HY27 and ABCA1 in patients with rheumatoid arthritis.
Supporting Evidence
- MTX+ subjects had significantly elevated ABCA1 and HY27 expressions compared to MTX- subjects.
- ABCA expression correlated with MTX doses.
- MTX+ subjects were more likely to have increased HY27 compared to MTX- subjects.
Takeaway
This study shows that taking a common arthritis medicine called methotrexate might help the body get rid of bad cholesterol better.
Methodology
100 rheumatoid arthritis patients were compared based on their use of methotrexate and other DMARDs, assessing blood lipid profiles and gene expressions.
Limitations
The study did not find significant differences in blood lipid profiles between groups, possibly due to low prevalence of dyslipidemia.
Participant Demographics
99 patients completed the study, with 67 using methotrexate and 32 not using it.
Statistical Information
P-Value
0.021 for ABCA1, 0.037 for HY27
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website